Sensitivity and predictive value of criteria for p53 germline mutation screening

被引:223
|
作者
Chompret, A
Abel, A
Stoppa-Lyonnet, D
Brugières, L
Pagès, S
Feunteun, J
Bonaïti-Pellié, C
机构
[1] Inst Gustave Roussy, INSERM, U521, Unite Rech Epidemiol Canc, F-94805 Villejuif, France
[2] Inst Gustave Roussy, Dept Pediat, F-94805 Villejuif, France
[3] Inst Curie, Serv Genet Oncol, F-75248 Paris 05, France
[4] Inst Gustave Roussy, Lab Genet Oncol, CNRS, UMR 1599, F-94805 Villejuif, France
关键词
D O I
10.1136/jmg.38.1.43
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
引用
收藏
页码:43 / 47
页数:5
相关论文
共 50 条
  • [21] PREDICTIVE TESTING FOR GERMLINE MUTATIONS IN THE P53 GENE - ARE ALL THE QUESTIONS ANSWERED
    EELES, RA
    EUROPEAN JOURNAL OF CANCER, 1993, 29A (10) : 1361 - 1365
  • [22] Simultaneous Adrenocortical Carcinoma and Neuroblastoma in an Infant With a Novel Germline p53 Mutation
    Courtney, Rachael
    Ranganathan, Sarangarajan
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2015, 37 (03) : 215 - 218
  • [23] Sex differences in cancer risk among germline p53 mutation carriers
    Chompret, A
    Brugières, L
    Bonaïti-Pellié, C
    Feunteun, J
    BRITISH JOURNAL OF CANCER, 2004, 91 (03) : 603 - 604
  • [24] Novel p53 germline mutation in a patient with Li-Fraumeni syndrome
    Wong, SS
    Lozano, G
    Gaff, CL
    Gardner, RJM
    Strong, LC
    Aittomäki, K
    Lindeman, GJ
    INTERNAL MEDICINE JOURNAL, 2003, 33 (12) : 621 - U8
  • [25] Epigenetic conversion on p53 pathway in human cancer: The clinical potential of p53 mutation status as a predictive biomarker for drug sensitivity by epigenetic treatment.
    Yamashita, Keishi
    Waraya, Mina
    Katoh, Hiroshi
    Ooki, Akira
    Kawamata, Hiroshi
    Nakamura, Kazunori
    Nishimiya, Hiroshi
    Erna, Akira
    Sidransky, David
    Watanabe, Masahiko
    CANCER RESEARCH, 2013, 73 (08)
  • [26] The prognostic value of p53 mutation in pediatric marrow hypoplasia
    Abo-Elwafa, Hasnaa A.
    Attia, Fadia M.
    Sharaf, Alzahraa E. A.
    DIAGNOSTIC PATHOLOGY, 2011, 6
  • [27] The prognostic value of p53 mutation in pediatric marrow hypoplasia
    Hasnaa A Abo-Elwafa
    Fadia M Attia
    Alzahraa EA Sharaf
    Diagnostic Pathology, 6
  • [28] Is the p53 gene mutation at prognostic value in hepatocellular carcinoma?
    Ng, IOL
    Fan, ST
    ARCHIVES OF SURGERY, 2000, 135 (12) : 1476 - 1476
  • [29] BETA-THALASSEMIA TRAIT - PREDICTIVE VALUE AND SENSITIVITY OF SCREENING CRITERIA
    ROWLEY, PT
    AMERICAN JOURNAL OF HUMAN GENETICS, 1978, 30 (06) : A112 - A112
  • [30] PROGNOSTIC AND PREDICTIVE RELEVANCE OF IMMUNOHISTOCHEMICALLY DETERMINED P53 MUTATION IN GLIOBLASTOMA
    Kempter, J.
    Gempt, J.
    Wiestler, B.
    Combs, S. E.
    Schlegel, J.
    Liesche-Starnecker, F.
    Schmidt-Graf, F.
    NEURO-ONCOLOGY, 2022, 24